3.20
Rezolute Inc (RZLT) 最新ニュース
Rezolute Stock: FDA Fast Track Fuels 2025 Breakout - MSN
Rezolute shares in focus after RA Capital discloses 9.9% stake - MSN
Rezolute, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
RZLT (Rezolute Inc.) drops 2.26% after Q1 2026 earnings report reveals wider than expected per-share loss. - Xã Vĩnh Công
RZLT (Rezolute Inc.) reports wider than expected Q1 2026 loss, shares edge higher even as earnings miss analyst estimates.High Volatility - UBND thành phố Hải Phòng
Rezolute (RZLT) Top Gainer | Q1 2026: Earnings UnderperformRegulatory Risk - Cổng thông tin điện tử tỉnh Lào Cai
Rezolute gains after positive FDA meeting over lead asset - MSN
Xoma Royalty Corporation Investigated by the Portnoy Law Firm - GlobeNewswire
Rezolute to present Phase 3 ersodetug data at medical meeting By Investing.com - Investing.com Australia
Rezolute to present Phase 3 ersodetug data at medical meeting - Investing.com
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting - The Manila Times
NervGen Pharma Corp. (NGEN) - Minichart
Rezolute (RZLT) Stock Under Pressure (Investor Concern) 2026-04-20Popular Trader Picks - Cổng thông tin điện tử Tỉnh Sơn La
Free cash flow per share of Rezolute, Inc. – MUN:6HV1 - TradingView
Rezolute (RZLT) Stock: Valuation Gap (-2.26%) 2026-04-18Correlation Analysis - Cổng thông tin điện tử tỉnh Tây Ninh
Rezolute, Inc. (NASDAQ:RZLT) Short Interest Down 21.2% in March - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Given Average Rating of "Hold" by Brokerages - MarketBeat
Rezolute: Caught Between Biology And Statistics, Initiating With Hold Rating (NASDAQ:RZLT) - Seeking Alpha
FDA flexibility isn’t absent but evolving regulations come with growing pains - BioSpace
Rezolute’s Phase 3 SunRIZE study for Ersodetug fails to meet primary and secondary endpoints despite analyst backing - MSN
Rezolute Insider Confidence Rewarded, Stock Hits US$379m Market Cap - simplywall.st
Risk On: Is Rezolute Inc a top pick in the sectorFed Meeting & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Price Action: Will Rezolute Inc stock go up in YEARDollar Strength & Weekly Market Pulse Updates - baoquankhu1.vn
RZLT Q2 2026 Earnings: Rezolute Inc. posts wider-than-expected loss, reports no revenue - UBND thành phố Hải Phòng
Rezolute stock gains after FDA meeting on Ersodetug program update - MSN
RZLT.O PE Ratio & Valuation, Is RZLT.O Overvalued - Intellectia AI
RZLT Technical Analysis & Stock Price Forecast - Intellectia AI
Rezolute, Inc. (RZLT) stock price, news, quote and history - Yahoo Finance UK
What is HC Wainwright's Estimate for Rezolute Q1 Earnings? - MarketBeat
Rezolute CFO Evans Daron buys $28,500 in RZLT stock By Investing.com - Investing.com South Africa
Rezolute CFO Evans Daron buys $28,500 in RZLT stock - Investing.com
Rezolute (RZLT) CFO adds 10,000 shares in open-market purchase - Stock Titan
Rezolute Inc (RZLT) Stock Price Quote Today & Current Price Chart - Capital.com
Rezolute Inc (RZLT) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Rezolute: Sell Rating Despite FDA Feedback From Type B Meeting For Ersodetug (NASDAQ:RZLT) - Seeking Alpha
H.C. Wainwright Maintains Rezolute(RZLT.US) With Buy Rating, Maintains Target Price $5 - Moomoo
Will Rezolute Inc outperform during market ralliesTrade Performance Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Rezolute Inc. (RZLT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Opaleye Management Inc.'s Rezolute Inc(RZLT) Holding History - GuruFocus
Volume Report: Will Rezolute Inc stock go up in YEAR2026 Dividend Review & Low Risk High Win Rate Picks - baoquankhu1.vn
Vanguard realigns reporting; no beneficial stake in Rezolute (RZLT) - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT) - The Globe and Mail
Rezolute (RZLT) Gains Upgrade Following Positive FDA Meeting - GuruFocus
大文字化:
|
ボリューム (24 時間):